CLEAR LABELS Act

Key Points

• Congress is considering a new law that would require medicine labels to clearly show exactly where your drugs are made. Currently, it can be difficult for consumers to tell which company or country actually manufactured the specific ingredients in their prescriptions.
• Drug companies would have to list the name and location of the original factory that made the medicine's active ingredients, as well as the factory that finished the final product. This information could be printed directly on the packaging or accessed through a QR code or a website link.
• This change aims to give patients and doctors more transparency about the global supply chain for medicine. If there is a safety issue or a recall at a specific factory overseas, people would be able to check their own medicine bottles to see if their pills came from that location.
• The rules would apply to both the raw ingredients used to make drugs and the final pills or liquids sold to consumers. Companies would also be required to provide a paper copy of this manufacturing information to any individual who asks for it.
• If passed, the government would create specific rules for how these labels should look. These new requirements would start at least one year after the final rules are finished, giving drug companies time to update their packaging and systems.